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In this paper, I explore risk factors for opioid use and abuse among juvenile justice 
system-involved adolescents convicted of a serious offense; a group known to 
experience high rates of substance abuse and dependence. Using the Pathways to 
Desistance dataset, I assess whether risk factors for substance use that includes 
opioids are distinct from the risk factors for other illicit substance use that does not 
including opioids (non-opioid substance use). I also explore how, if at all, the motives 
and patterns of opioid use are distinct for male and female adolescent offenders. I 
identify older age, white race, and clinically significant mental illness as significant 
risk factors for substance use including opioids relative to non-opioid substance use. I 
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Chapter 1: Introduction and Literature Review 
An alarming uptick in adolescent substance abuse and death, starting in the 
late 1990s, has been attributed primarily to the growing epidemic of opioid misuse in 
the United States (Curtin et al., 2017). Drug overdose deaths increased 15 percent for 
males and 35 percent for females aged 15-19 between 2013 and 2015; more than two-
thirds of these deaths were attributable to opioids (Curtin et al., 2017). Opioid-related 
fatalities have increased fourfold since 1999, and deaths due to synthetic opioids like 
fentanyl have increased 540 percent in the past three years (Rudd et al., 2015; 
O’Donnell, 2017).  Further, opioid misuse was estimated to cost the U.S. $504 billion 
in 2015 (Florence et al., 2016). Accordingly, opioid misuse has been highlighted as 
an urgent public health and criminal justice problem in the U.S. (Rudd et al., 2015; 
O’Donnell, 2017; Warner et al., 2016).  
The opioid epidemic is driven largely by increases in prescription opioid 
misuse among young adults, however, opioid use, particularly prescription opioid use, 
is also a growing problem among adolescents. This matters because when opioid use 
begins in adolescence, users are significantly more likely to develop drug dependence 
and less likely to receive substance abuse treatment relative to users who begin later 
in life (Palamer et al., 2016). Hospital admissions due to opioid exposures for 
adolescents doubled between 1997 and 2012 (Gaither et al., 2016). While adolescents 
report higher levels of prescription opioid than heroin use, increases in adolescent 
deaths are primarily due to heroin, and other drugs laced with the synthetic opioid 





have occurred while rates of use for most other drugs have remained stable or 
declined (Jones et al., 2015; Warner et al., 2016). In 2015, for example, 25 percent of 
adolescents reported never using alcohol or marijuana compared to only two percent 
of adolescents in 1975 (Johnston et al., 2016). 
Increases in opioid use are facilitated, in part, by a greater variety of available 
prescription opioids and because physicians have prescribed these medications at an 
increased rate since the mid-1990s (Kilmer et al., 2014; Muhuri et al., 2013). This is 
notable because most opioid users, including adolescents, begin with prescription 
opioids (Ahrsnback et al., 2017).  Supply of heroin has also increased in parallel to 
the rising availability of prescription opioids, and prices for heroin have decreased 
consistently each year since 2001. (Compton et al., 2016; Kilmer et al., 2014). One 
study found that each $100 decrease in the cost per gram of heroin was associated 
with a 2.9 percent increase in heroin overdose related hospitalizations (Unick et al., 
2014).   
In this paper, I will explore risk factors for opioid use among juvenile justice 
system-involved adolescents, a group known to experience high rates of substance 
abuse and dependence. I will also examine whether these risk factors are distinct from 
the risk factors for non-opioid substance use.  This population merits exploration 
because opioids are more likely to be prescribed to youth who already have risk 
factors for substance use disorders. For example, adolescents with pre-existing mental 
health disorders (not including substance use disorders) are more likely to receive 
opioids and more likely to receive long-term prescriptions for opioids than 





SAMHSA, 2016). This is troublesome for reasons that extend beyond increasing 
access to prescription opioids among an already high-risk population.  
Adolescents who misuse prescription opioids report that they are most likely 
to get the drugs from friends, so increases in prescription opioids may reach more 
adolescents than intended (SAMHSA, 2016; Jones et al., 2015; Ahrsnback et al., 
2017). Further, among heroin users, those who report prior prescription opioid misuse 
are more likely to meet the criteria for a substance use disorder than those who do not 
report prior prescription opioid misuse (Jones, 2013). Further, youth who have used 
prescription opioids are more likely to go on to use heroin (Jones, 2013; Ahrsnback et 
al., 2017). Among high school students who report use of heroin, more than three in 
four students (over 75 percent) began with prescription opioids (Palamar et al., 2016). 
Another study found that adults who misuse prescription opioids are 19 times more 
likely to initiate heroin use than adults who do not misuse prescription opioids 
(Muhuri et al., 2013).   Qualitative studies examining the transition from prescription 
opioid misuse to heroin use find that users view heroin as more available and more 
cost-effective than prescription opioids (Cicero et al., 2014;  Lankenau et al., 2012; 
Mars et al., 2014; Pollini et al., 2011). Last, I want to explore sex differences in 
adolescent opioid use since prior research suggests that young adults are more likely 
to engage in opioid use than younger teens. Contrary to trends for the overall 
population, among those aged 12-17, opioid use is more prevalent among adolescent 
females than males, a phenomenon driven primarily by prescription opioid misuse 





The relationship between opioid abuse and other substance abuse among juvenile 
offenders 
Research consistently finds that justice system-involved youth in the U.S. 
report higher levels of substance abuse than their uninvolved peers (Chassin, 2008; 
Office of Applied Studies, 2003). Three-quarters of detained females and nearly two 
thirds of detained male adolescents meet the criteria for a substance use disorder 
diagnosis (Teplin et al., 2002; McClelland et al. 2004). Many justice-involved 
adolescents also report current substance use; up to 65 percent of males and up to 55 
percent of females test positive for illegal drug use at the time of arrest (Dembo et al., 
1999; Zhang, 2004).  
There is limited research on opioid abuse among juvenile offenders, but 
research finds that adolescents who engage in “hard drug” use are more likely to 
engage in polydrug use, and have higher exposure to an array of risk factors 
compared to adolescents who engage in alcohol or marijuana use alone.  One 
longitudinal study of serious juvenile offenders found that seven percent reported 
opiate use at the baseline reporting year, compared to 80 percent who reported using 
marijuana and 80 percent who reported using alcohol (Mulvey et al., 2010). These 
rates were nearly twice that of their same-age peers who are not involved in the 
juvenile justice system (Ahrsnback et al., 2017). While this demonstrates that 
proportionally fewer juvenile offenders report opioid abuse than abuse of other 
substances, it does not describe the different characteristics or experiences that lead to 
drug use for juvenile offenders who abuse opioids. Further, death due to opioid use is 





prevention. One reason for the lack of information specific to opioid abuse among 
juvenile offenders is that a substantial portion of research treats alcohol and other 
drug use (“AOD”) as a monolithic indicator of risk (Kilpatrick et al., 2000; Wiesner 
& Capaldi, 2005; Trim et al., 2015). This research finds that there are several 
overlapping risk factors for substance use and juvenile justice system involvement, 
including: male gender, low self-control, early initiation of substance use, history of 
mental illness, low levels of parental monitoring, negative peer influence, and 
exposure to traumatic experiences. (Trim et al., 2015, SAMHSA, 2016; Hawkins, et 
al., 1992).  
Juvenile offenders who desist from substance use are more likely to desist 
from offending, as well. Youth who desist from substance abuse early are less likely 
to become persistent offenders into adulthood (Chassin, 2008; Office of Applied 
Studies, 2003; Mulvey et al., 2010).  Juvenile offenders who report high levels of 
substance use are more likely to recidivate, report antisocial behaviors, engage in 
property crime, and are less likely to engage in prosocial behaviors (D’Amico et al., 
2008; Schubert et al., 2011). It is important, then, to explore patterns of opioid abuse 
among juvenile offenders to better understand whether existing interventions 
targeting substance abuse behavior, and risk factors that may lead to substance abuse 
behaviors, among juvenile offenders are also adequate for addressing opioid abuse.  
Females in the juvenile justice system may be at a higher risk for opioid use 
because relative to males, they are more likely to have a mental health diagnosis or to 





counterparts to come into contact with the juvenile justice system for low level 
offenses, such as substance use. (Huizinga & Miller, 2013).   
I will explore the risk factors for opioid abuse among adolescents, whether 
these risk factors are different for opioids compared to other illicit substances, and 
how, if at all, the motives and patterns of opioid use are distinct for male and female 
adolescent offenders. Specifically, I will explore the following research questions:  
• How do risk factors for opioid abuse differ from risk factors for other drug use 
among system-involved adolescents?  
• How do risk factors for opioid abuse differ for system-involved males and 
females? 
Disentangling the unique risk factors, motives, and experiences that facilitate 
distinct types of illicit drug use may be important for understanding the types of 
rehabilitative services that juvenile offenders need. This may also help the research, 
policy, and program communities respond to changing trends in drug use and poly-
drug use among juvenile offenders.   
Review of the Literature 
Risk factors for opioid abuse and other substance abuse among juvenile 
offenders 
Research on adolescent substance use in general suggests that risk factors for 
adolescent opioid abuse and dependence may be distinct from risk factors for other 
illicit substances. There is limited research available on opioid use specifically, but 





anxiety and other mental health symptoms, and delinquent behavior while frequency 
of marijuana use was only predicted by antisocial peers and delinquent behavior, 
hallucinogen use was predicted by age and social problems, and binge drinking was 
predicted by all of these risk factors (Nation & Heflinger, 2006). Below, I review risk 
factors for substance abuse in general and present theoretical explanations for why 
these risk factors may be associated with opioid abuse, when appropriate. I am also 
interested in exploring whether distinct risk factors are related to opioid abuse for 
female versus male adolescent offenders. Accordingly, I also highlight evidence of 
gender differences and theoretical explanations for these differences specific to each 
risk factor. 
Age   
Though prevalence of most substance use peaks around 17 years, increases in 
opioid abuse have been observed most prominently among young adults aged 18-25 
(Johnston et al., 2013; Jones et al., 2015).  Heroin use, for example, increased 109 
percent among young adults ages 18-25 between 2011 and 2013 (Jones et al., 2015). 
While levels of heroin use among high school students remain low, at less than one 
percent of high school students, the number of high school age adolescents who tried 
heroin for the first time in the past year continues to increase (Hughes et al., 2016; 
Johnston et al., 2013). While opioid use peaks around age 18-25, other substance use 
declines after peaking around age 17. Continued increases in use beyond age 17, then, 
may be a unique predictor for opioid use. It remains unclear, however, whether age 







Rates of substance abuse among black, white, and non-white Hispanic 
adolescents are similar (Saloner et al., 2014). White and non-white Hispanic youth 
report roughly similar levels of alcohol and other illicit substance use and abuse, 
which is slightly higher than rates of use abuse among black youth (Swendsen et al., 
2012). Opioid abuse seems to be equally prevalent among white individuals and in 
some communities, even more prevalent among white individuals (Cicero et al., 
2014; Hedden, 2015; Hughes et al., 2016).  In the past 20 years, heroin use has 
increased across all ethnic groups but has increased most among non-Hispanic whites 
(Cicero et al., 2014; Heden, 2015; Jones et al., 2015;). Youth of color are 
overrepresented in the juvenile justice system, so it merits exploration whether race 
and ethnicity serve as a protective factor against opioid abuse among this population.    
Self-Control 
Personality traits, including sensation seeking, impulsivity, aggression, and 
social withdrawal are associated with an increased risk of substance abuse during 
adolescence (Flexon et al., 2016; Nation & Heflinger, 2006; Wiesner et al., 2005). 
Many of these personality traits are studied as measures of a broader indicator of self-
control. Low self-control is one of the most reliable predictors of antisocial behavior 
(Flexon et al., 2016; Pratt & Cullen, 2000). In a study of drug treatment among 
serious adult offenders, impulsivity and sensation seeking personalities were 
negatively associated with desisting from opioid abuse. These same factors were 





2013). Additionally, high self-control appears to buffer the effects of stressful life 
events and peer substance use on adolescent substance abuse (Willis et al., 2008).  
The General Theory of Crime provides a theoretical explanation for the 
influence of self-control on adolescent substance abuse. The General Theory of Crime 
reasons that low self-control, impulsive behavior, and inability to delay gratification 
in early childhood are strong and consistent risk factors for offending and 
“analogous” risk behaviors later in life (Gottfredson and Hirschi, 1990). Gottfredson 
and Hirschi (1990) argue that individuals who exhibit low self-control in early 
childhood are not able to see the long-term consequences of their actions. These 
individuals tend to be thrill seeking and lack future orientation. Consistent with this 
theory, research finds that conduct problems and aggression in early childhood 
predict substance use in adolescence (Wiesner et al., 2005). Literature also shows 
initiation of substance use before adolescence is associated with an increased 
likelihood of engaging in criminal offending in adolescence (Huizinga et al., 1995). 
Further, low self-control has been found to predict a variety of substance use 
behaviors, including opiates, marijuana, and cocaine (De Wit, 2009). Self-control is 
likely an important predictor for opioid use, but evidence does not suggest that self-
control is a stronger predictor of opioid use than other drug use.  
Co-occurring mental health problems 
Mental illnesses, not including substance use disorders, have been linked to 
greater likelihood as well as higher levels of opioid abuse. In a study examining how 
risk factors predict adolescent substance use, extreme anxiety predicted opioid use, 





found that 70 percent of individuals with an opioid abuse disorder had a co-occurring 
mental health diagnosis (Rounsaville et al., 1985).  
Adolescent offenders are at an increased risk of having a substance use 
disorder. When adolescent offenders have a substance use disorder, they are more 
likely to meet the criteria for another co-occurring mental health diagnosis. Seventy 
percent of adolescent offenders satisfy the criteria for a mental health disorder and 30 
percent satisfy the criteria for post-traumatic stress disorder; these rates are 
significantly higher than their uninvolved peers (Dierkhising, 2013). Mental illness 
appears to be an important predictor of all types of substance use, but may be a 
particularly strong predictor for opioid use.  
Prior delinquent behavior 
When youth initiate risk behaviors such as substance use and delinquency at 
an early age, it increases the likelihood of subsequent risk behavior, including 
continued substance abuse and offending (Lipsey & Derzon, 1998). Research also 
finds a dose-response effect, with higher engagement in substance use predicting 
increased likelihood of offending, increased severity of the offenses committed, and a 
longer period of overall criminal offending (Hoeve, et al. 2015; Lipsey &Derzon, 
1998; Wiesner et al., 2005). Prior delinquent behavior predicts many types of 
substance use, including opioid use. In a study examining how various risk factors 
predict substance use, delinquent behavior predicted involvement in all types of drug 
abuse, including opioid abuse, except for use of hallucinogens (Nation & Heflinger, 
2006). A meta-analysis on type of drug use and criminal offending finds that opioid 





use except for crack cocaine (Bennett, et al., 2008). Prior delinquency, then, may be 
an especially strong predictor of opioid use.  
Parental monitoring and parental substance abuse 
Low parental monitoring and parental substance abuse are associated with increased 
risk for adolescent opioid abuse, as well as abuse of other illicit substances (Nation & 
Heflinger, 2006; Weinberg, 2001). When parental monitoring is high, adolescents are 
less likely to engage in substance use because there is a greater opportunity of getting 
caught. Parental monitoring in early childhood is also associated with greater self-
control later in life. Indeed, parental monitoring is a strong predictive factor against 
many types of substance use (Lac & Crano, 2009; Ford, 2009). Adolescents may 
model parents’ substance use behaviors leading to increased likelihood of adolescent 
substance use (Li et al., 2009).  Low parental monitoring may also increase 
adolecents’ access to their parents prescription opioids. Further, when parents have 
substance use disorders, households typically have lower incomes, lower levels of 
monitoring, and less engaged parenting practices (Griffin et al., 2000). While parental 
substance use may influence adolescent opioid use, there is not evidence that this 
relationship would be any stronger for adolescent opioid use relative to other drug 
use.   
Peer relationships  
Peer substance abuse is a robust predictor of adolescents’ substance abuse behavior 
(Monahan et al., 2009; Oxford et al., 2001). Peer substance abuse is a strong predictor 





abuse (Nation &Heflinger, 2006; Weinberg, 2001). Additionally, strong connections 
to prosocial friends appear to buffer the relationship between low self-control and 
substance abuse for adolescents (Baker, 2010). One way that peer networks increase 
the likelihood of opioid abuse is when peers deal to or share drugs with their friends. 
Most opioid users access drugs through peer networks; this finding has been 
replicated in studies with adults, young adults, and high school students (Keyes et al., 
2014; McCabe et al., 2012). Akers (1985) Social Learning Theory suggests that 
behavior is learned in intimate social groups, such as peer groups. When peer groups 
reinforce antisocial behaviors, an adolescent is likely to continue engaging in that 
behavior. Peers are likely an important influence for many types of substance use, but 
may be particularly important in opioid use because delinquent peers may increase 
access to opioids.  
Trauma and stressful life events 
Stressful life events such as parents’ divorce, exposure to violence, 
victimization, and health problems among family members are associated with 
initiation of substance abuse and levels of substance abuse over time, including 
opioid abuse (Nation &Heflinger, 2006). One study found that adolescents who were 
victimized or witnessed violence were more than two times as likely to engage in 
substance abuse (Kilpatrick et al., 2000).  
Juvenile offenders are disproportionately likely to have experienced stressful 
life events; 90 percent report exposure to at least one traumatic event (Dierkhising, 
2013). One study among juvenile offenders found that childhood sexual abuse, but 





(Smith & Saldana, 2013). Other studies have documented a strong relationship 
between trauma and substance abuse (Abram et al., 2007; Chassin, 2008).   
Strain theories suggest that adolescents’ risk behaviors are a response to a 
stressful life event, or in many cases, multiple exposures to traumatic or stressful 
events. Agnew’s General Strain Theory (1992) proposes that delinquent behavior 
may result from three categories of strain: the failure to achieve positively valued 
goals, exposure to noxious stimuli, and the removal of positive stimuli. According to 
GST, exposure to strain causes a negative emotional response which necessitates a 
coping mechanism. The coping mechanism is more likely to be associated with 
antisocial behavior when the strain is severe, unjust, or associated with negative 
emotions (Agnew, 2001). Trauma is prevalent for the majority of justice system 
involved youth. While trauma likely plays an important role in adolescent substance 
use, the evidence is not compelling that trauma has a stronger effect for opioids than 
for other substances.  
Gender differences in risk factors for opioid use 
U.S. data consistently find that gender matters when examining prevalence of 
substance use and substances of choice (SAMHSA, 2016; Smith, 2014).  For 
example, females are more likely than males to report prescription opiates or heroin 
as their primary drug and males are more likely than females to report marijuana as 
their primary drug (Greenfield et al., 2010). Further, male gender is one of the 
strongest predictors of non-opioid substance abuse for adolescents who offend and 
those in the general population alike (Chassin, 2008). Since the late 1990s, heroin and 





among females relative to their male counterparts, representing a departure from 
trends in abuse of other illicit substances (Rudd et al., 2016; Cicero et al., 2014).  
Gender alone cannot logically explain these differences in substance use; it is 
likely that other risk factors moderate the relationship between gender and opioid use. 
The risk factors and motivations leading to substance abuse may differ by gender, 
however. For example, females may have greater access to opioids because they are 
prescribed opioids at a higher rate than their male counterparts (Isacson,et al., 2002; 
Green et al., 2009). A history of other substance use may also be a stronger correlate 
of opioid abuse for females than for males. In a study examining treatment seeking 
adults in the general population, history of overdose and problem drinking were 
correlates for opioid abuse for females but not for males (Sansone et al., 2009; Leve 
et al., 2015). These trends from the general population suggest that exploration of the 
factors that moderate the role of gender on opioid use among adolescents in the 
juvenile justice system merits attention.   
 There is evidence that gender differences in substance use vary by age. For 
example, rates of substance use dependence are similar among males and females 
ages 15-17. After age 18, however, males are twice as likely as females to report 
substance use dependence (SAMHSA, 2016; Smith, 2014). Among those aged 18-25 
admitted for substance abuse treatment, 18 percent of females reported prescription 
opiates were their primary drug and just 13 percent of males (Smith, 2014). 
Understanding how age interacts with gender can provide a more thorough 





Some research has found a moderating effect of impulsivity on gender for 
alcohol use; impulsivity was an important predictor of alcohol use for males and 
females, but a greater predictor for females (Stoltenberg et el., 2008). A study of 
young adults seeking treatment for opioid dependence found that insufficient self-
control was the most prevalent risk factor among males and females, but that a greater 
proportion of the females reported insufficient self-control (Shorey et al., 2012). 
According to the General Theory of Crime, gender differences in antisocial 
behaviors, such as opioid and other drug use, are a result of differential levels of self-
control between males and females. Accordingly, males engage in more substance 
abuse because they have lower levels of self-control than females. One study found 
that after controlling for self-control and opportunity to commit crime, gender 
differences in adolescent alcohol and marijuana use were eliminated, however, which 
suggests that self-control mediates the relationship between gender and substance use. 
This study used parental monitoring as a measure of opportunity, however, and 
females reported significantly higher levels of monitoring than their male 
counterparts. (LaGrange & Silverman, 1999). Although evidence is mixed, lower 
levels of self-control may be an important predictor of substance use for both males 
and females but may be associated with a greater risk for opioid use among females 
than for males.  
Several studies have found that female opioid abusers are more likely than 
males to report mental illness (Green et al., 2009; Sansone et al., 2009; Leve et al., 
2015). For example, one study of treatment seeking opioid abusers found that the risk 





male patients (Darke et al., 1992). Female adolescent offenders are more likely to 
have a substance abuse disorder and a diagnosis of substance use dependence than 
their male counterparts, which also increases the risk of a co-occurring mental health 
diagnosis (LaGrange & Silverman, 1999; Teplin et al., 2002).  Research examining 
whether mental illness moderates the relationship between gender and substance use 
among adolescents, however, provides mixed results (Schwinn et al., 2010). For 
example, some studies have found that depression and anxiety have been associated 
with higher rates of substance use among adolescent females but not among males. 
Other research has found no association between depression and differential levels of 
substance use among male and female adolescents (Acierno et al., 2010; Patton et al., 
2002; Galambos et al., 2004).  
There is mixed evidence that peer influence moderates the relationship 
between gender and opioid use. The role of peers appears on adolescent substance 
abuse has been found to be greater for males than females. Males and females with 
similar levels of delinquent peer influence, however, report differential levels of 
substance use (McCabe et al., 2007; Dara et al., 2003). Other research finds that these 
gender differences can be explained by differential levels of parental monitoring for 
males and females. The protective effects of parental monitoring can buffer negative 
peer influence (Svennson, 2003).   Research on opioids also suggests that peers are an 
important predictor of opioid use. A study of opioid abuse among high school 
students found that females were more likely than males to share their prescription 





Trauma is an important predictor of substance use for females. A breadth of 
research finds that justice-involved adolescent females are up to twice as likely as 
males to experience physical and sexual child abuse, exposure to other traumatic life 
events, and early substance abuse (Kerig & Ford, 2014; Smith & Saldana, 2013). This 
study found that for justice-involved female adolescents, sexual abuse was 
significantly related to stimulant, opioid, and depressant use but not to abuse of 
hallucinogens, inhalants, or prescription “club” drugs (Smith & Saldana, 2013). Girls 
who end up in the juvenile justice system are disproportionately likely to have 
experienced childhood abuse, including physical and sexual abuse. Victimization, 
thus, is an important part of girls’ (and women’s) pathway to delinquency. The 
coping mechanisms that girls are likely to employ in response to trauma are the same 
behaviors that are likely to result in their incarceration, including running away, 
truancy, and substance use. Research examining the link between childhood abuse, 
running away, and arrest yield mixed results. The literature agrees that experiencing 
abuse or neglect in childhood increases the risk of juvenile arrest later in life, for both 
genders. One study found that abuse and running away increased the likelihood of 
arrest but abuse alone did not directly predict likelihood of arrest. Running away, 
regardless of abuse history, was found to increase risk of arrest (Kauffman & Widom, 
1999). 
Research finds that among individuals who experience high levels of strain, 
females are more likely to abuse substances as a coping mechanism or a form of self-
medication than are males (Kerig & Ford, 2014). Females are more likely to respond 





(Broidy and Agnew, 1997). Males, on the other hand, are more likely to externalize 
their emotional response to strain. Thus, GST may offer a better explanation for 
female’s substance use (Agnew, 1997; Broidy, 2001).  While it is important to 
account for females’ prior exposure to traumatic life events, the literature provides 
some evidence for both a moderating and mediating role of strain on gender and 
opioid use. 
Implications for the current study 
Risk factors describe characteristics or experiences that increase an 
individual’s likelihood of engaging in substance abuse, but presence of risk factors 
does not imply a causal relationship.  One reason that it is difficult to establish a 
causal relationship between risk factors and risk behaviors among juvenile offenders 
is that there is substantial overlap in risk factors for substance abuse and risk factors 
for offending. Some studies find that substance abuse and offending are interrelated 
and participation in one behavior may increase the severity of participation in the 
other. For example, one study conducted with juvenile offenders in Los Angeles 
found that opioid abuse, as well as abuse of other illicit substances, and delinquency 
had reciprocal effects: participation in one increased likelihood of participation in the 
other (D’Amico et al., 2008). Another complicating factor in understanding the role 
of risk factors is that the effects of many risk factors are mediated by other factors 
(Baker, 2010; Forgays, 1998).  
Each of the factors reviewed above, low self-control, mental illness, , deviant 
peer relationships, prior delinquent behavior, and strain, may contribute to opioid 





review of the literature, it appears that some of these risk factors may be particularly 
strong predictors of opioid use relative to other substance use. Additionally, in line 
with research on substance abuse in general, gender appears to play an important role 
in the pathway to initiation and persistence of opioid abuse for juvenile offenders, 
though for many risk factors evidence is mixed.  Specifically, factors that have some 
evidence of moderating the relationship between gender and opioid abuse include: 
age, self-control, mental illness, peer relationships, and strain.  
This thesis will explore the following hypotheses: 
• H1: Among adolescents who offend, the constellation of risk factors for 
opioid abuse are different than risk factors for other drug use. Specifically: 
o H1a: Female gender will be more strongly related to opioid use and 
abuse than other drug use and abuse.  
o H1b: Older age will be more strongly related to opioid use and abuse 
relative to other drug use and abuse. 
o H1c: Being white relative to another race will be more strongly related 
to opioid use and abuse relative to other drug use and abuse. 
o H1d: Mental illness will be more strongly related to opioid use and 
abuse relative to other drug use and abuse. 
o H1e: Greater prior offending will be more strongly related to opioid 
use and abuse relative to other drug use and abuse.  
o H1f: Delinquent peers will be more strongly related to opioid use and 
abuse relative to other drug use and abuse. 
 
• H2: Among adolescents who offend, female opioid users will have a 
constellation of risk factors that is different than their male counterparts. 
Specifically: 
o H2a: Being older and female will be associated with greater risk of 
opioid use and abuse than being older and male. 
o H2b: Being female with low levels of impulse control will be 
associated with a greater risk of opioid use and abuse relative to 
having low impulse control and being male.  
o H2c: Females with a mental illness will have a greater risk of opioid 
use and abuse than males with mental illness. 
o H2d: Females who report more delinquent peer behavior will have a 
greater risk of opioid use and abuse than males who report more 





o H2e: Females with higher exposure to strain will have an increased 
risk of opioid use and abuse relative to males who have higher 







Chapter 2: Methods 
The purpose of this study is to test the hypotheses that 1) risk factors for opioid 
use are distinct from risk factors for other substance use for justice system involved 
youth, and 2) that there are differences in these risk factors for females relative to 
males. Accordingly, I used multinomial logistic regression to analyze how well, if at 
all, the risk factors identified in the literature review above predict ordinal measures 
of opioid use after baseline. In the multinomial logistic regression, for a one unit 
increase in the independent variable, the relative risk ratio represents the change in 
the risk ratio for the dependent variable in one group relative to the dependent 
variable in the reference group.  I compare the risk ratios in these models for 
substance use including opioid use relative to non-opioid substance use and relative to 
no substance use among a sample of juveniles convicted of a felony offense. I tested 
for a moderating relationship of female gender on my hypothesized predictors of 
opioid use using interactions of female gender with each of the risk factors in the 
model. To assess the relationship between age and opioid use and gender I conducted 
a longitudinal logit model, looking at age and opioid use each year to determine 
whether, as hypothesized, age of opioid use for a high-risk group is lower than typical 
opioid use in the general population and whether the age when opioid use is most 
prevalent differs for males and females. I repeated this process with opioid use as the 





Description of the data 
I will use the publicly available Pathways to Desistance dataset, a longitudinal survey 
of 1,354 serious juvenile offenders. The Pathways to Desistance study enrolled 
serious juvenile offenders ages 14 to 20 at the time of their committing offense 
between November 2000 and January 2003 in Maricopa County, Arizona or 
Philadelphia, Pennsylvania. Youth were recruited between 2000 and 2003 and 
followed for seven years, leaving the study between 2007 and 2010. During this time, 
opioid use sharply increased, particularly prescription opioid use, and opioid use 
among white individuals (Alexander et al., 2017). After 2010, opioid use continued to 
increase, and is projected to continue increasing for the next two decade. After 2010, 
however, opioid use shifted from prescription opioids to synthetic opioids like 
fentanyl and heroin. Thus, during the study period, increases in opioid use are largely 
attributable to prescription opioids. Youths’ qualifying offenses were primarily 
felonies, but in some cases misdemeanor property offenses, sexual assaults, and 
weapon offenses were included. The study team capped the proportion of males 
found guilty of a drug charge at 15 percent to avoid over representation of drug 
offenders. Twenty percent of youth that were asked to participate in the study 
declined to participate.  
The study team recruited 1,354 adjudicated adolescents aged 14-20 when they 
committed the offense that made them eligible for the study. About 41 percent of 
youth were placed on probation, 21 percent were placed in a non-incarceration out-of-






Pathways data are primarily based on adolescent self-report. Adolescents completed 
eleven surveys. The baseline interview was conducted in 2000 within 75 days of the 
adjudication hearing for youth in the juvenile system. For youth in the adult system, 
the baseline interview was conducted within 90 days of the decertification hearing for 
Pennsylvania youth and within 90 days of the adult arraignment hearing for Arizona 
youth. The difference for youth in the adult system is due to Arizona having no 
provision for waiving youth back to the juvenile system.  
In addition to the baseline interview, follow-up interviews were conducted at six, 12, 
18, 24, 30, 36, 48, 60, 72 and 84 months post-baseline. The study teamed maintained 
90 percent of the sample throughout the entire follow-up period. The interviews cover 
six domains: 1) background characteristics, 2) indicators of individual functioning, 3) 
psychosocial development and attitudes, 4) family context, 5) personal relationships, 
and 6) community context. 
 Adolescents used computer assisted survey interview software and trained 
interviewers read the questions aloud. Interviews took place in-home, in public 
locations, or in facilities. To maximize privacy, respondents could choose to enter 
their responses on a keypad instead of responding verbally to the interviewer. Self-
report information was validated through interviews with collateral reporters, a family 
member or friend, and official records such as FBI records of arrest and juvenile and 
adult records from the appropriate jurisdiction (Schubert et al., 2004).  
Study Sample 
I measured my independent variables at baseline and my key dependent 





baseline survey and at least one follow-up survey to ensure measurement is available 
for every individual on the key variables. This exclusion removed 18 cases from the 
study sample. Characteristics of the overall sample and the study sample are 
comparable as shown in Table 1. The exclusion of these 18 cases did not appear to 
disproportionately affect demographic characteristics or estimates of opioid abuse for 
those in the study sample compared to the original sample.  
The mean age at baseline in the study is about 16 years. Roughly 21% of adolescents 
included in the study are white, 41% are black, and 34% are Hispanic. Most of the 
adolescents in the study did not report opioid use at baseline. Table 1 shows that 
males and females in the sample have roughly similar baseline characteristics. 
However, a greater proportion of females (26.9%) are white compared to the male 
subpopulation (20%).   





















Race/Ethnicity (%)    
White 20.23% 20.51% 19.50% 26.92% 
Black 41.43% 40.94% 41.59% 36.81% 
Hispanic 33.53% 33.83% 34.40% 30.22% 
 
Table 2 shows substance use at baseline. Opioid use in the past six months is slightly 
higher for females at baseline (4.4%) than males (3.6%). All other substance use 




























































In this paper, I focus on opioid use, the use of opioids for non-medically 
indicated purposes, and abuse, the repeated use of opioids for a non-medically 
indicated purpose. Opioids are a class of drugs that include heroin, fentanyl, and 
prescription pain relievers like oxycodone, hydrocodone, codeine, morphine, and 
others. This opioid use variable captures anyone who reported using opioids one or 
more time during the recall period. This measure captures “recreational users” as well 
as heavier users. Opioid abuse captures repeat users of opioids; or those who report 





As shown in Table 3, I found substantial overlap between opioid use and other 
substance use at each follow up. For example, at baseline every person who reported 
opioid use also reported marijuana use Accordingly, it is unrealistic to assess risk 
factors for opioid use without considering polysubstance use. Taking this into 
consideration, I constructed two ordinal measures for my dependent variables: 
polysubstance use including opioid use and polysubstance abuse including opioid 
abuse. I refer to these as measures of opioid use and opioid abuse.   
 
 To measure opioid use, I constructed a variable with three mutually exclusive 
categories: “0” represents no substance use at all; “1” represents substance users that 
do not report opioid use; and “2” represents opioid users and other substance users. 
To construct this variable, I drew from several substance use measures. Specifically, I 
used measures asking about frequency of opiate, alcohol, marijuana, cocaine, ecstasy, 
and hallucinogen use in the recall period.1 Each of these is an ordinal measure asking 
how many times youth used the respective substance in the recall period on a scale 
from “never” to “every day.” Most youth at each follow up period reported that they 
“never” used each of the substances. The ordinal measure, therefore, did not provide a 
                                                 
1 The recall period is the time since the last interview, unless specified otherwise. For most interviews 
there were six months in the recall period, but for the last three interviews there are 12 months in 





lot of variation. I dichotomized the measures of substance use to indicate youth who 
reported any opiate, marijuana, cocaine, ecstasy or hallucinogen use, respectively. For 
alcohol use, I wanted to capture binge drinking rather than any alcohol use. The 
National Institute of Drug Abuse states the binge drinking occurs when an individual 
is drunk five or more days in a month. Accordingly, I coded binge drinking as “1” if 
respondents reported being drunk once a week or more. For each substance, (opioids, 
binge drinking, marijuana, cocaine, ecstasy, and hallucinogens) I then aggregated the 
dichotomous measure of substance use across follow up periods two through eleven 
by coding substance use as “1” if the youth reported using the substance at any 
follow-up period between two and eleven. I then constructed the ordinal measure of 
polysubstance use including opioid use: If a respondent reported never engaging in 
any substance use, they are coded as “0”; If a respondent reported any binge drinking, 
marijuana, cocaine, ecstasy, or hallucinogen use but no opioid use, they were coded 
as a “1”; if a respondent reported any opioid use, regardless of whether they reported 
any other substance use, they were coded as “2”. For substance use, 16.32 percent of 
respondents reported no use, 68.94 percent reported substance use but no opioid use, 
and 14.75 percent reported substance use including opioid use.   
I operationalize opioid abuse in a parallel way. I constructed a variable where 
“0” represents no substance abuse at all, “1” represents substance abusers who do not 
report opioid abuse, and “2” represents opioid abusers and other substance abusers.  I 
dichotomized opioid, marijuana, cocaine, ecstasy and hallucinogen abuse as reporting 
the respective substance use “three or more times” at any follow up period. I 





per week or more at any follow-up period. This is in accordance with guidelines from 
the National Institute of Drug Abuse. For substance abuse, 25.52 percent of 
respondents reported no abuse of any substances, 62.65 percent reported substance 
abuse not including opioid abuse, and about 11.83 percent reported substance abuse 
including opioid abuse. As shown in Table 4, the average response for opioid abuse, 
0.86, is somewhat lower than the average response for opioid use, 0.98. The average 
response is comparable for males and females in the study sample.  








 Mean SD Mean SD Mean SD 
Opioid use (and other substance 
use) 0.98 0.56 0.99 0.56 0.97 0.57 
Opioid abuse (and other substance 
use) 0.86 0.60 0.86 0.6 0.85 0.60 
Independent Variables 
The independent variables for hypothesis one include: age, white race, female gender, 
mental illness, prior delinquent behavior, and delinquent peer influence. I also control 
for baseline substance use. The independent variables for hypothesis two include: 
age, female gender, impulse control, delinquent peer influence, and exposure to 
violence. As in hypothesis one, I also control for baseline substance use.  
Race/Ethnicity 
 I created three dichotomous variables from a nominal measure of youth’s self-
reported race/ethnicity at baseline. These three dichotomous variables identify 
whether the adolescent is Hispanic, Black, or White. As shown in Table 1, about 20 
percent of the sample is white, 41 percent is black, and 34 percent is Hispanic. Five 





reference category (“0”) for each variable. I use white race as an independent variable 
in hypothesis one and two.  
Age 
To assess the relationship between age, opioid use and abuse, and gender I used a 
continuous measure of age at each follow-up period to examine hypothesis 1b and 
hypothesis 2a. I also used a continuous measure of youth’s age at baseline as a control 
variable in the multivariate models for the remaining hypotheses. As shown in Table 
5, the mean age at baseline was about 16 years. Most of the sample (96 percent) was 
15-18 at the baseline interview. Forty-three individuals (3.4 percent) were age 14, 
eleven individuals (about one percent) were 19, and one was 20 (<one percent).  
Gender 
I included a variable identifying whether adolescents are female based on their 
reported gender at baseline. As shown in Table 5, about 14 percent of the sample is 
female.  
Self-Control 
I used a measure of impulse control which represents the mean of eight questions on 
impulsivity from the Weinberger Adjustment Inventory (Weinberger &Schwartz, 
1990). Each question was answered on a scale from False to True (False, Somewhat 
False, Not Sure, Somewhat True, True). Higher mean scores indicate greater impulse 
control. Previous research with the pathways dataset has found that this subscale is 
reliable (Cronbach alpha=.76) (Mulvey et al., 2010). As shown in Table 5, the mean 
for the impulse control variable is 3.36 out of 5 indicating that on average participants 






Youth responded to the 53-item Brief Symptom Inventory (Derogatis & Melisaratos, 
1983) based on the extent to which they experienced psychiatric symptoms in the past 
week. I used a variable that includes the number of subscales which reach clinical 
significance. There are nine subscales: somatization, obsessive-compulsive, 
interpersonal sensitivity, anxiety, hostility, phobic anxiety, paranoid ideation, and 
psychoticism. Range for the variable is 0-9, where 0 is no subscales reaching clinical 
significance and 9 is clinical significance on all subscales. I dichotomized the variable 
to indicate presence of at least one clinically significant mental illness at baseline. As 
shown in Table 5, about 22 percent of the sample reported at least one clinically 
significant mental illness.  
 Prior Delinquent Behavior 
Youth may only be included in this sample if they have a history of prior delinquent 
behavior. I used a continuous measure of offending variety indicating the number of 
types of criminal acts in the past year over the total number of offending questions to 
which youth responded. Research finds that prior offending variety is often a better 
predictor of future behavior than frequency of prior offeding (Hindelang et al., 1981; 
Monahan & Piquero, 2009). A study with the Pathways dataset found concordance 
between prior offending variety and frequency of prior offending measures (Monahan 
& Piquero, 2009).  Proportions closer to 1 indicate more offending variety. For 
example, if youth provided non-missing responses to five delinquent acts and 
reported participation in four acts, their offending variety would be 4/5 or .8 As 






Youth responded to the Peer Delinquent Behavior items indicating how many of their 
friends encourage them to engage in seven items from the same Peer Delinquent 
Behavior Items scale. Responses were measured on the scale from “none of them” to 
“all of them.” Youth must have responded to at least five of the seven items in order 
for the mean to be computed. As shown in Table 5, on average youth reported that 
very few of their friends (scale value=2.13) encouraged them to engage in delinquent 
behaviors.  
Trauma and stressful life events 
To measure strain, I used a measure constructed from a modified version of the 
Exposure to Violence Inventory (Selner-O'Hagan, Kindlon, Buka, Raudenbush,& 
Earls, 1998). This measure includes frequency of violent events that the adolescent 
witnessed as well as experienced. Scores range from 0 events to 13 events. Higher 
scores indicate exposure to more violent events.  As shown in Table 5, youth were 
exposed to an average of 5.35 violent events.  
Baseline substance use and abuse 
To control for substance use and abuse at baseline, I constructed two variety scales of 
substance use and abuse. I first dichotomized baseline opioid, marijuana, cocaine, 
ecstasy, and hallucinogen use as well as binge drinking following the same guidelines 
used to construct the dependent variable for opioid use. At baseline, respondents were 
asked about substance use in the past six months. Thus, if respondents reported using 
a substance at least once in the past six months, I coded them as “1”. I then created a 





ranges from “0”, indicating no substance use at baseline, to “6” indicating they used 
each of the substances. I followed a parallel procedure for the baseline substance 
abuse variety scale. As shown in Table 5, the average baseline substance use variety 
scale score was 1.11 and the average baseline substance abuse variety scale score was 
0.80; these numbers are similar for males and females in the study sample. Further, 
this table shows that there are somewhat large differences in presence of a clinically 
significant mental health disorder between males and females (19.05% and 36.42%, 
respectively). 
Table 5. Descriptive statistics for independent and control variables 

























Clinically Significant Mental 
Illness 1,224 
21.46% 


































I began by descriptively examining the relationship between substance use and abuse 
and each of the independent variables. To examine Hypothesis 1b: Age will be more 
strongly related to opioid use and abuse relative to other drug use and abuse I 





variables, which are measured at baseline, I examined age as a time-varying covariate 
to see how, if at all, age and substance use covary at each follow up period. After 
looking at patterns of age and opioid use and abuse over time, I conducted bivariate 
multinomial logistic regression models to determine whether age was a significant 
predictor of opioid use or abuse relative to non-opioid substance use/abuse and 
relative no substance use/abuse. For these bivariate models, I clustered at the 
individual level to account for the same individual providing up to eleven responses 
each (one per survey).  
I then collapsed opioid use and abuse across all follow up time points and conducted 
multinomial logistic regression models with baseline predictors to assess which risk 
factors are associated with adolescent substance use and abuse including opioids 
relative to non-opioid substance use and to no substance use. More specifically, I 
compared the risk of individuals coded as “2,” use/abuse substances including opioids 
relative to “1” individuals who use use/abuse substances not including opioids, and to 
“0” individuals who do not use/abuse any substances. I report findings from the 
comparison of substance use that includes opioids (the “2s”) relative to non-opioid 
substance use (the “1s”) and do not report findings for substance use including 
opioids relative to no substance use or non-opioid substance use relative to no 
substance use. For these aggregated analyses, I started by conducting bivariate 
analyses with opioid use and abuse and each of the key independent variables. I then 
ran the full model with all independent and control variables (age and baseline 
substance use/abuse). To assess model fit, I used the model chi square fit statistic.  I 





significant in the model. After arriving at the final model, I calculated relative risk 
ratios for each covariate. 
To assess whether the risk factors for substance use that includes opioids are distinct 
from non-opioid substance use I compared the risk ratio for substance use that 
includes opioids relative to non-opioid substance use. To assess gender differences, I 
first examined the relationship between opioid use and abuse and age by gender at 
each follow-up period. I then ran bivariate logistic regression models by gender for 
opioid use and age to determine whether age was a significant predictor of opioid use 
or abuse.  In each model, I clustered at the individual level to adjust standard errors 
for non-independence of error terms.  Then, I once again collapsed opioid use and 
abuse across all follow periods and created interactions between gender and each of 
the independent variables. In this model I considered age and baseline substance 
use/abuse control variables, so I do not create interactions with these items.  To assess 
whether risk factors for opioid use and abuse are distinct for females, I interpreted the 
interaction terms. 
Finally, because clinically significant mental illness has significant missing data 
(n=1,224), I ran the multivariate models for hypothesis one and hypothesis two 
without it and assessed any differences between the restricted (without mental illness) 






Chapter 3: Results 
Hypothesis 1 
I begin by descriptively examining patterns of substance use and abuse and the time-
varying covariate, age at each follow-up. Figure 1 shows substance use including 
opioid use and substance abuse including opioids for participants at each wave. Rates 
of opioid use and abuse are elevated at baseline and then start to increase again 
around the eighth follow-up period (five years after baseline). Prior to arrest, 
individuals may have been engaged in overall higher levels of risk behaviors, 
including substance use. Increases after the seventh follow-up period may correlate 
with increases in age for the study population, described below and shown in Table 6. 
Depending on when youth joined the study, the eighth follow up period was between 
2005 and 2008. Sharp increases in opioid use in the U.S. overall began in the early 
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Figure 1. Percent substance use and abuse including 
opioids by year






I hypothesized that age would be a more important risk factor for opioid use relative 
to other substance use. Specifically, I expected more significant increases in opioid 
use with age relative to other substance use. As shown in Table 6, the data appear to 
support this hypothesis; opioid use and abuse increase with age. Like individuals in 
the general population, in this sample opioid use is more prevalent among 









To assess whether age is a more robust predictor of opioid use and abuse relative to 
non-opioid substance use, I ran bivariate multinomial logistic regressions with non-
opioid substance use as the reference category and clustered on the individual.  I do 
not report findings for substance use that includes opioids relative to no substance 
use. As shown in Table 7, the risk of substance use including opioids relative to non-
opioid substance use is higher for older adolescents. The relative risk for a one-year 
increase in age is 1.10 for substance use including opioids use relative non-opioid 
substance use and this is significant at p<.01.  
 
Table 6. Substance use and abuse including opioids by age 
Age Opioid use Opioid abuse 
14 1.95% 0.98% 
15 1.50% 0.75% 
16 2.55% 1.67% 
17 2.23% 1.38% 
18 2.33% 1.48% 
19 1.97% 1.44% 
20 2.56% 1.15% 
21 4.61% 2.93% 
22 3.98% 2.43% 
23 4.30% 2.65% 





Table 7. Bivariate multinomial logit opioid use, abuse and age 
Relative risk of substance use including opioids vs. non-opioid substance use 
RRR SE 
1.10* 0.03 
Relative risk of substance abuse including opioids vs. non-opioid substance abuse 
RRR SE 
1.10* 0.03 
*indicates significance at p<.01, two-tailed 
 
Similarly, the risk of substance abuse including opioid abuse relative to non-opioid 
substance abuse is higher for older adolescents. The relative risk for a one-year 
increase in age is 1.10 relative to non-opioid substance abuse; this is significant at 
p<.01. Findings from these bivariate models support Hypothesis 1b: Age will be more 
strongly related to opioid use and abuse relative to other drug use and abuse.  
To assess whether the constellation of risk factors for substance use including opioid 
use and abuse are distinct from risk factors for non-opioid substance use and abuse, I 
collapsed measures of opioid use and abuse across follow up periods.  I first ran 
bivariate models with opioid use and abuse and the key independent variables: female 
gender, white race, mental illness, prior offending variety, and delinquent peer 
influence. Relative risk ratios and standard errors from the bivariate multinomial 
logistic regression models for opioid use are shown in Table 8, and results for the 
substance abuse models are shown in Table 9.  
Table 8. Bivariate multinomial logit results, opioid use 
 
Relative risk of substance use including opioids vs. non-
opioid substance use  
RRR SE N 
Female 0.98 0.23 1,336 
White 3.41* 0.57 1,336 
Mental illness 1.88* 0.34 1,244 





Peer influence 1.26* 0.10 1,321 
* Indicates significance at p<.01, two-tailed 
 
The risk of substance use including opioids relative to non-opioid substance use is 
higher for white youth, those with mental illness, those with a higher prior offending 
and those who score higher in the negative peer influence scale. Female gender is not 
significant, but the relative risk ratio suggests that being female is associated with a 
slightly decreased risk of substance use that includes opioids relative to non-opioid 
substance use (RRR 0.98). Youth who are white are at an increased risk of substance 
use that includes opioids relative to substance use that does not include opioids (RRR 
3.41, p<.01). Youth who have a clinically significant mental illness are also at an 
increased risk of substance use that includes opioids relative to substance use that 
does not include opioids (RRR 1.88, p<.01). An increase in prior offending variety is 
also associated with an increased risk of substance use that includes opioids relative 
to non-opioid substance use (RRR 5.86, p<.01). Scoring one unit higher on the scale 
of negative peer influence is associated with an increased risk of substance use that 
includes opioids relative to substance use that does not include opioids (RRR 1.26, 
p<.01). 
Table 9. Bivariate multinomial logit results, opioid abuse  
Relative risk of substance abuse including opioids vs. non-
opioid substance abuse  
RRR SE N 
Female 0.98 0.25 1,336 
White 2.19* 0.41 1,336 
Mental illness 1.48b 0.30 1,244 
Prior offending 2.38 1.14 1,333 
Peer influence 0.97 0.09 1,321 
*Indicates significance at p<.01, two-tailed 





Fewer risk factors reach significance in the bivariate models for substance abuse 
including opioids: only white race and having a clinically significant mental illness. 
As in the model of substance use, female gender is not significant, but the relative 
risk ratio suggests that being female is associated with a slightly decreased risk of 
substance abuse that includes opioids relative to non-opioid substance abuse (RRR 
0.98). Also parallel to the substance use model, being white is associated with an 
increased risk of substance abuse including opioids relative to non-opioid substance 
abuse (RRR 2.19, p<.01). Having a clinically significant mental illness is associated 
with an increased risk of substance abuse including opioids relative to non-opioid 
substance abuse (RRR 1.48, p<.10). Prior offending variety is not significant, but the 
relative risk ratio suggests that having a greater prior offending variety is associated 
with an increased risk of substance abuse including opioids relative to non-opioid 
substance abuse (RRR 2.38). Negative peer influence is also not significant, but 
contrary to the hypothesized relationship, the relative risk ratio suggests that 
increased negative peer influence is associated with a decreased risk of substance 
abuse including opioids relative to non-opioid substance abuse (RRR 0.97).    
Multivariate models of substance use 
I then ran the full multivariate models of substance use and abuse with all 
independent variables (female, white race, clinically significant mental illness, prior 
offending variety, and delinquent peer influence). I also included relevant control 





models of substance use are shown in Table 10, and Table 11 displays results for the 
multivariate models of substance abuse. 2  
Table 10. Multivariate multinomial logit results, opioid use  
Relative risk of substance use including opioids vs. 
non-opioid substance use, N=1,229 
 
RRR SE 
Female 0.75 0.19 
White 3.07* 0.56 
Mental illness 1.76* 0.35 
Prior offending 1.44 0.87 
Peer influence 1.08 0.11 
Age 0.93 0.07 
Baseline substance use 1.29* 0.09 
*Indicates significance at p<.01, two-tailed 
 
Table 11. Multivariate multinomial logit results, opioid abuse  
Relative risk of substance abuse including opioids vs. 
non-opioid substance abuse, N=1,229 
 
RRR SE 
Female 0.83 0.23 
White 2.10* 0.42 
Mental illness 1.55a 0.33 
Prior offending 1.86 1.22 
Peer influence 0.85 0.10 
Age 0.96 0.08 
Baseline substance use 1.15b 0.10 
*Indicates significance at p<.01, two-tailed 
a Indicates significance at p<.05, two-tailed 
b Indicates significance at p<.10, two tailed 
 
H1a: Female gender will be more strongly related to opioid use and abuse than other 
drug use and abuse. 
As shown in Table 10, female gender is not a significant predictor of opioid use 
relative to non-opioid use, but the relative risk ratio suggests that females are at less 
                                                 
2 I also ran the models without clinically significant mental illness and found no differences compared 





risk of opioid use than males (RRR 0.75). Similarly, as shown in Table 10, female 
gender is not a significant predictor of substance abuse including opioids relative to 
non-opioid substance abuse, but the direction of the risk ratio suggests females are at 
a decreased risk of opioid abuse (RRR 0.83). Neither the use nor abuse results support 
my hypothesis.  
H1c: Being white relative to another race will be more strongly related to opioid use 
and abuse relative to other drug use and abuse. 
Being white relative to another race is associated with an increased risk of substance 
use including opioids relative to non-opioid related substance use (RRR 3.07, p<.01). 
Similarly, being white relative to another race is associated with an increased risk of 
substance abuse including opioids relative to non-opioid substance abuse (RRR 2.18, 
p<.01). Findings from both the use and abuse models support my hypothesis. 
H1d: Mental illness will be more strongly related to opioid use and abuse relative to 
other drug use and abuse. 
Having a clinically significant mental illness is associated with an increased risk of 
substance use that includes opioids relative to non-opioid substance use (RRR 1.76, 
p<.01). Having a clinically significant mental illness is also associated with an 
increased risk of substance abuse that includes opioids relative to non-opioid 
substance abuse (RRR 1.55, p<.05). Findings from both the use and abuse models 
support my hypothesis. 
H1e: Greater offending variety will be more strongly related to opioid use and abuse 
relative to other drug use and abuse.  
A one unit increase in prior offending variety suggests an increased risk of 1.44 for 
substance use that includes opioids relative to non-opioid substance use, but the 
relative risk ratio is not significant. A higher prior offending is also associated with an 





substance abuse, but the relative risk ratio is not significant (RRR 1.86). Results from 
the use and abuse models do not support my hypothesis. 
H1f: Delinquent peers will be more strongly related to opioid use and abuse relative 
to other drug use and abuse. 
A one unit increase on the scale of delinquent peer influence suggests an increased 
risk of substance use including opioids relative to non-opioid substance use, but the 
relative risk ratio is not significant (RRR 1.08). In contrast, a unit increase on the 
scale of delinquent peer influence suggests a decreased risk of substance abuse 
including opioids relative to non-opioid substance abuse, but this relative risk ratio is 
also not significant (RRR 0.85). Results from the use and abuse models do not 
support my hypothesis.  
As shown in Table 12, the models presented above provided support for my 
hypotheses pertaining to age, white race, and clinically significant mental illness as 
significant risk factors for substance use including opioid use and abuse. I did not find 
support for my hypotheses pertaining to gender, prior delinquency, or delinquent 
peers. Results from the use and abuse models coincided for every risk factor.  





H1a: Female gender will be more strongly related 
to opioid use and abuse than other drug use and 
abuse.  
X X 
H1b: Age will be a more strongly related to opioid 
use and abuse relative to other drug use and abuse. 
    
H1c: Being white relative to another race will be 
more strongly related to opioid use and abuse 
relative to other drug use and abuse. 
    
H1d: Mental illness will be more strongly related to 
opioid use and abuse relative to other drug use and 
abuse. 





H1e: Greater offending variety will be more 
strongly related to opioid use and abuse relative to 
other drug use and abuse.  
X X 
H1f: Delinquent peers will be more strongly related 





I began by looking at patterns of opioid use and abuse by gender. As shown in Figure 
2, females report greater levels of opioid use at baseline and first follow-up but fall 
below their male peers at the second follow up (12 months).  
 
 
To assess significant gender differences in opioid use by age, I ran a bivariate 
multinomial logistic regression clustering on the individual. Results from bivariate 
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FIGURE 2. PERCENT OPIOID USE BY GENDER 






Table 13. Bivariate Multinomial Logit Results, opioid use and abuse and 
age by gender  
Relative risk of substance use including opioids vs. 
non-opioid substance use 
 
 
RRR SE N 
Female 1.04 0.07 1,911 
Male 1.10* 0.03 11,567  
Relative risk of substance abuse including opioids 
vs. non-opioid substance abuse 
 
Female 1.12 0.12 1,911 
Male 1.10* 0.03 11,567 
*Indicates significance at p<.01, two-tailed 
 
For females, the relative risk ratios suggest that an increase year of age is associated 
with an increased risk of 1.04 for substance use including opioids relative to non-
opioid substance use, but the relative risk ratio is not significant. The results from the 
opioid abuse model are similar: an increased year in age for females is associated 
with an increased risk of 1.12 for substance use including opioids relative to non-
opioid substance use, but this relative risk ratio does not reach significance.  
For males, an increased year of age is associated with an increased risk of non-opioid 
substance use relative to non-opioid substance use (RRR 1.10, p<.01).  The results 
from the opioid abuse model are similar: an increased year of age for males is 
associated with an increased risk of substance use including opioids relative to non-
opioid substance use (RRR 1.10, p<.01).  
The risk ratios for opioid use relative to non-opioid substance use are similar for 
males and females, however, the standard errors are greater for females leading to 
null findings. The high standard errors for females may be due in part to the relatively 





older and female will be associated with greater risk of opioid use and abuse than 
being older and male. 
To examine whether female opioid users have a constellation of risk factors distinct 
from their male peers, I began by running regressions with each independent variable, 
female gender, and an interaction term for female gender and the independent 
variable. Results from these models are shown in Table 14.  
Table 14. Multivariate multinomial logit results, opioid use 
with gender interaction by construct 
  Relative risk of substance use 
including opioids vs. non-opioid 
substance use 
  RRR SE 
Impulse control, N=1,333  
Female 0.75 0.60 
Impulse control 0.65* 0.06 
Impulse Control*Female 1.09 0.27 
Clinically significant mental illness, N=1,244  
Female 1.05 0.32 
Mental illness 2.11 0.41 
Mental illness*Female 0.57 0.28 
Peer influence, N=1,321 
Female 0.60 0.38 
Peer influence 1.23 0.10 
Peer influence*Female 1.27 0.33 
Exposure to violence, N=1,333  
Female 1.79 0.80 
Exposure to violence 1.07a 0.03 
Exposure*Female 0.89 0.07 
*Indicates significance at p<.01, two-tailed 
a Indicates significance at p<.05, two-tailed 
 
As shown in Table 14, being female relative to male was not associated with 
increased risk of substance use including opioids relative to non-opioid substance for 





models. The same is true for the models of substance abuse including opioids relative 
to non-opioid substance abuse (see Table 15). 
Table 15. Multivariate multinomial logit results, opioid abuse 
with gender interaction by construct 
  Relative risk of substance abuse 
including opioids vs. non-opioid 
substance abuse 
  RRR SE 
Impulse control, N=1,333  
Female 0.92 0.83 
Impulse control 0.84b 0.08 
Impulse Control*Female 1.02 0.27 
Clinically significant mental illness, N=1,244 
Female 0.90 0.31 
Mental illness 1.50b 0.33 
Mental illness*Female 0.98 0.53 
Peer influence, N=1,321 
Female 1.13 0.77 
Peer influence 0.97 0.09 
Peer influence*Female 0.93 0.28 
Exposure to violence, N=1,333  
Female 1.15 0.57 
Exposure to violence 1.02 0.03 
Exposure*Female 0.97 0.09 
b Indicates significance at p<.10, two-tailed 
 
These initial models with gender interactions suggest there is no support for 





Chapter 4: Limitations and Discussion 
Limitations 
There are a few limitations to this study. A primary limitation of the study is that, due 
to the significant overlap in different types of substance use, I was unable to isolate 
individuals who exclusively used opioids. The prevalence of polysubstance use 
among opioid users limits my ability to identify unique risk factors for opioid use. 
Additionally, I was not able to control for number of days in detention during each 
follow up period. Participants in secure detention may have less access to opioids 
than those who are not in secure detention. Just over half (51.2%) of respondents 
were in secure detention at baseline which suggests that detention may have played 
an important role in access to opioids for a substantial proportion of the sample. 
Participants in secure detention may also have been more likely to receive 
wraparound services like counseling for substance abuse disorders or other substance 
abuse treatment which may also lead to decreased likelihood of engaging in substance 
use. For the majority of my analyses I aggregated substance use after baseline, so not 
controlling for substance abuse treatment was likely not a major limitation of the 
study. Detention status may explain the unexpected trend in opioid use with time; 
opioid use was more prevalent among youth at age 16, less prevalence between ages 
17-19, and increased again at age 20. It is possible that the decline in opioid use 
during the later teen years is attributable, in part, to placement in secure detention 
where there is limited access to illicit substances. Another limitation is that the length 





from six months to one year. This longer exposure window may have allowed for 
more time for opioid use to occur, accounting for increases in opioid use in the later 
years.  
Another limitation is that data were collected during the rise of the opioid epidemic in 
the US, between 2000 and 2010. I did not measure or control for increased 
availability and use of opioids overall, which may have influenced these findings. 
Additionally, the key independent and dependent variables in the study relied on 
adolescent self-report. Some research has found that adolescents are reliable reporters 
of their own risk behaviors, but it would be optimal to include corroborative 
reporting. Finally, the generalizability of these results is limited as the data are not a 
random sample of all juvenile justice system involved youth; data are collected only 
from adolescents who committed a serious crime in Phoenix, Arizona or Maricopa 
County, Pennsylvania.  
Discussion 
 
Increases in opioid use and deaths attributable to opioid use since the late 1990s have 
garnered significant attention of the research and policy communities. Increased 
public attention may also be due, in part, to the fact that the opioid epidemic affects 
populations that are not expected to be at risk of engaging in substance use such as 
white, middle and upper class young adults. From 2000-2010, deaths attributable to 
opioids occurred predominantly among white individuals and were largely caused by 
misuse of prescription opioids. Individuals in the general population who misused 
opioids did not typically misuse a variety of other substances. Based on these patterns 





among a population known to be at high risk for engaging in substance use, juvenile 
justice system involved youth.  I examined whether risk factors were distinct for 
substance use that includes opioids relative to non-opioid substance use.  
I found that, overall, opioid use among juvenile justice system involved youth is best 
understood in the context of polysubstance use more broadly. At baseline, all opioid 
users in the sample also used marijuana, and many used other substances as well.  I 
found a few risk factors were associated with increased risk for substance use that 
includes opioids relative to non-opioid substance use: older age, white race, and 
presence of a clinically significant mental illness. These risk factors parallel risk 
factors for opioid use among individuals in the general population. In the general 
population, opioid use is more common among young adults than adolescents, and 
this appears to be the case among this in-risk sample as well. Being white is also 
significantly associated with substance use including opioids relative to substance use 
that does not include opioids, a finding that also parallels trends from the general 
population.  
That youth with a clinically significant mental illness are more likely to use opioids 
also parallels findings from studies with youth in the general population. Some 
studies have found, for example, that individuals with mental illnesses are more likely 
to be prescribed opioids for pain than individuals who do not have mental illnesses.  
I also found that female gender, prior offending variety, and delinquent peer influence 
are not associated with an increased risk of opioid use or abuse relative to non-opioid 
substance use and abuse. Prior offending variety was associated with increased risk of 





models (RRR 5.86, p<.01), as was delinquent peer influence (RRR 1.26, p<.01).  The 
absence of any significant relationship between prior offending variety or delinquent 
peer influence and opioid use in the multivariate model may be due to their high 
correlation with prior substance use because after controlling for prior substance use, 
these factors are no longer significant in the model.  Another potential explanatory 
variable may be age. Prior offending variety and delinquent peer influence are robust 
predictors of adolescent risk behaviors such as substance use and future delinquency 
but may not do as well at explaining risk behaviors among young adults.  
A primary aim of this study was to examine how, if at all, gender predicts opioid use 
and abuse relative to non-opioid substance use and abuse. A substantial body of 
literature suggests that among adolescents overall, females are more likely to identify 
opioids as their primary drug of choice than are males. Additionally, there were larger 
increases in opioid use among females than males between 2000 and 2010. This is 
notable because male gender is one of the most robust predictors for all non-opioid 
substance use.  Given these trends in the overall population, I wished to examine how 
similar the relationship between female gender and opioid use would be among 
juvenile justice system involved adolescents relative to patterns among adolescents 
overall. I expected to find unique predictors for females’ opioid use and abuse. More 
specifically, I expected female gender to moderate the relationships between age, 
self-control, mental illness, strain and opioid use. Contrary to my hypotheses, gender 
was not a significant predictor or moderator of substance use or abuse including 





There are a few possible explanations as to why predictors of opioid use 
among female adolescents convicted of a serious offense are no different than those 
of their male counterparts. I found no support that female gender was a significant 
predictor of substance use including opioids relative to non-opioid substance use. 
Research conducted among adolescents and young adults in the general population 
suggests that females are more likely to use opioids, but this typically involves 
prescription opioids. Further, most adolescents get access to prescription opioids 
through their friends and family members. Juvenile justice system involved females 
may simply have more limited access to prescription opioids than females in the 
general population, leading to a preference for more readily accessible alternatives. 
On the other hand, it is possible that females who exhibit more high-risk behavior, 
such as the females who might end up in this sample, are subject to higher levels of 
monitoring possible from caregivers or through involvement with the juvenile justice 
system, which could limit access to prescription opioids. Also, because I was unable 
to control for detention status, females may have been subject to more monitoring 
through disproportionate stays in detention facilities, which would decrease their 
access to opioids and reduce their overall risk for opioid use.  
I also found no effect for any of the interaction terms with gender and each 
risk factor I examined. This suggests that female gender does not moderate the 
relationship between risk factors and substance use. It is possible the processes that 
lead adolescents to be involved in the juvenile justice system, and further, to be 
convicted of a felony or similarly “serious” offense, differ for males and females. For 





less likely to have committed nearly all crime types than their male counterparts 
except for running away and prostitution. I did not have measures for adolescents’ 
specific offense histories, thus did not explore crime severity as a predictor. Females 
are less likely than males to be arrested, but once they enter the juvenile court system 
they are more likely to be sentenced to detention for lower level crimes than their 
male counterparts. Male adolescents who are involved in the juvenile justice system 
are more likely than their female counterparts to be charged with a violent crime or a 
drug-related crime (Hogdon, 2013). It is possible, then, that females who enter the 
juvenile justice system represent a lower risk group than males who enter the juvenile 
justice system. If males’ propensity for risk behavior in the sample is elevated above 
that of the females’, and more so than would be expected among adolescents overall, 
this could explain why I did not find any predictors of opioid use that were more 
robust for female adolescents.  
Further, these data are also only representative of adolescents who were 
convicted of a serious crime, thus the results do not reflect patterns among juvenile 
justice system-involved adolescents more broadly. Females are disproportionately 
likely to be arrested for low level offenses, and are more likely to receive secure 
detention for a lower level offense relative to their male counterparts. Often, 
adolescent females are convicted of crimes that correspond to coping mechanism for 
strain including substance abuse, running away, and status offenses. Differences in 
how and why adolescents are sentenced contribute to differences in risk factors and 
outcomes for males versus females in the juvenile justice system overall. Among this 





differences between males and females, or that females in a sample of serious 
juvenile offenders are more similar to their male counterparts than females and males 
in the juvenile justice system in general. Adding to this selection issue, the proportion 
of male respondents enrolled in the study who were convicted of a drug offense was 
capped at 15% while there was no cap for females convicted of a drug offense. The 
group of females may be more representative than the male group, but females may 
also have been more likely to be assigned to substance abuse treatment than males. 
Finally, prior literature has found mixed evidence for the moderating role of 
some of the variables I examined in this study. For example, previous literature has 
found support for both moderating and mediating roles of self-control, mental illness, 
and delinquent peers on gender and substance use. It is possible, then, that some of 
these risk factors mediated rather than moderated the relationship between female 
gender and substance use. This does not seem to be the case for self-control, which, 
based on the main effect variable, appears to reduce the risk associated with substance 
use including opioids relative to non-opioid substance use (RRR .84, p<.10). 
Additionally, the main effect for peer influence is not significant and close to one, 
suggesting this may not be a mediator (RRR 0.97). Mental illness, however, is 
associated with an increased likelihood of substance use involving opioids relative to 
non-opioid substance use (RRR 1.5, p<.10). This may indicate that after controlling 
for mental health status, gender differences in opioid use are eliminated. It is 
impossible to say whether mental illness acts as a mediating variable without more 





Implications for research and policy 
 
A primary takeaway from this study is that opioid use among juvenile justice system 
involved youth almost never occurs in the absence of other drug use. Researchers 
must approach studies of opioid use in the context of polysubstance use. Further, 
policies aimed at prevention, screening, and intervention, may benefit from targeting 
efforts toward other substance users.  
Developmental theories of offending suggest that most individuals tend to desist from 
delinquent behavior, including substance, use by young adulthood. If engaging in 
opioid use is associated with persistence of delinquency, then these individuals may 
need targeted attention not only with substance abuse treatment, but also with tasks 
related to transitioning to adulthood. Thus, substance abuse treatment programs may 
be more beneficial if they incorporate components such as job training, healthy 
relationships programming, and other adult skills. 
In line with trends for other substance use, and in line with trends for 
adolescents overall, system involved adolescents who are white are more likely to 
engage in substance use that includes opioids relative to non-opioid substance use. 
This may point to greater access or availability of these substances for white youth. It 
may also suggest that white youth perceive less risk associated with engaging in 
opioid use. Future research could examine whether risk perceptions vary by race.  
I also found that youth with a clinically significant mental illness are more 
likely to engage in substance use that includes opioids relative to non-opioid 
substance use. Youth with mental illness are more likely to be prescribed opioids for 





prescription opioid users are more likely to go on to use heroin. Further, heroin abuse 
often co-occurs with mental illnesses.  Thus, adolescents with a mental illness may be 
at increased risk for longer term, and more dangerous patterns of opioid use. All 
adolescents prescribed opioids should be closely monitored and informed of the risks 
associated with their medicine, but youth with mental illness may benefit from 
additional check ins with practitioners.  
Future research should aim to better unpack the relationship between gender 
and opioid use. Given the variety of selection processes at play when studying 
system-involved adolescents, it may be hard to answer this question through 
secondary data alone. For example, research should examine the relationship between 
gender, mental illness, and opioid use. In this study, females had a higher prevalence 
of mental illness than males, but mental illness was not a more significant predictor of 
opioid use for females relative to males.  
 Focus groups or interviews may provide more illuminating and nuanced 
information about the reasons system-involved females and males do or not prefer 
opioids, and to tap into the presence of other risk factors. Additional research using 
secondary data may provide additional insight by including measures of caregiver 
monitoring and detention stays that may have influenced females’ access to opioids. 
This may be particularly important given prior literature that finds females are subject 
to higher levels of monitoring than their male counterparts.  
Finally, future research should examine risk factors for opioids among other 
high-risk populations, such as youth involved in the child welfare system and youth in 





increased risk for substance use. Although there is some overlap between these 
populations and the juvenile justice population, the selection processes vary from that 
of the juvenile justice system. Accordingly, there may be more significant findings by 
gender in these other at-risk populations.   
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